{
    "nctId": "NCT04498611",
    "briefTitle": "Prediction of Upgrade to Invasive Cancer in Patients Diagnosed With Ductal Carcinoma in Situ by Percutaneous Core Needle Biopsy",
    "officialTitle": "Prediction of Upgrade to Invasive Cancer in Patients Diagnosed With Ductal Carcinoma in Situ by Percutaneous Core Needle Biopsy: A Development and Validation Study",
    "overallStatus": "COMPLETED",
    "conditions": "Carcinoma, Ductal, Breast, Invasive Breast Cancer, IMAGE",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 113,
    "primaryOutcomeMeasure": "Comparing of Preoperative MRI and Postoperative histopathologic results",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Adult over 19 years-old\n* Breast Ductal Carcinoma in-situ patients who diagnosed preoperative tissue biopsy\n* A person who understands this study and agrees with willingness to participate\n\nExclusion Criteria:\n\n* Ductal Carcinoma in-situ which diagnosed excisional biopsy\n* When there is no lesion that can be discriminated from magnetic resonance imaging\n* Neoadjuvant chemotherapy patients\n* Patients who have complication (hematoma, abscess etc.) after preoperative biopsy",
    "sex": "ALL",
    "minimumAge": "19 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}